Cleveland Clinic AI Maps New Drug Targets for Brain Health

Cleveland Clinic researchers have developed a new artificial intelligence framework called GenT to accelerate drug discovery ^[1]. This system identifies disease-associated genes for complex brain conditions like Alzheimer’s, depression, and schizophrenia ^[1]. The framework helps scientists pinpoint where new treatments could be most effective within human DNA ^[2].

Traditional methods often struggle to link specific genes to brain diseases due to biological complexity ^[1]. GenT solves this by integrating genomic data for more accurate results ^[2]. This tool could lead to personalized medicine for patients with neurodegenerative or psychiatric disorders ^[1].